This report provides exclusive insights into the COVID-19 impact on the Needle Free Drug Delivery Devices Market. The detailed analysis provides information about the impact of the outbreak on the demand and supply conditions, trends and forecasts of the Needle Free Drug Delivery Devices Market. Moreover, the impact analysis covers the study of the COVID-19 on the supply chain of Needle Free Drug Delivery Devices Market. The sectoral impact shall provide insights into both short term and long term effects of the pandemic on the related and support industries.
A recent report published by Infinium Global Research on needle
free drug delivery devices market provides an in-depth analysis of segments and
sub-segments in the global as well as regional needle free drug delivery
devices market. The study also highlights the impact of drivers, restraints,
and macro indicators on the global and regional needle free drug delivery
devices market over the short term as well as long term. The report is a
comprehensive presentation of trends, forecast and dollar values of global
needle free drug delivery devices market. According to the report, the global
needle free drug delivery devices market is projected to grow at a CAGR of 10.3%
over the forecast period of 2019-2025.
The growing incidences of chronic diseases like HIV AIDS, Dengue,
and Hepatitis are the major factors that are driving the growth of the global
needle free drug delivery devices market across the globe. According to the
World Health Organization, HIV continues to be a major global public health
issue, having claimed more than 32 million lives so far. Nearly, 770 000 people
died from HIV-related causes across the globe in 2018. On the other hand,
increasing demand for regular administration of the drug in diseases like
hepatitis and dengue also plays a key role in the growth of the global market.
Furthermore, the occurrence of well-developed healthcare facilities and
extensive research and development costs by government administrations and
pharmaceutical companies for diabetes and chronic pain organization are also
fueling the growth of the needle free drug delivery devices market. However,
high initial costs of needle free drug delivery devices may restrain the growth
of the market. Moreover, technological advancements in terms of pain-free drug
transportation and self-administration create an opportunity for the growth of
the global needle free drug delivery devices market in the upcoming years.
In terms of region, the global needle free drug delivery devices
market is categorized into North America, Europe, Asia Pacific and the Rest of
the World. Among all regions, North America is leading the global needle free
drug delivery devices market due to increasing incidences of chronic diseases.
Furthermore, high awareness relating to novel drug delivery systems among the
patient base also plays a vital role in the growth of the market in the North
American region. The Asia Pacific is expected to grow at a beneficial rate
during the forecast period. This is attributed to the increasing elderly
population, the growing occurrence of diabetes in developing countries such as
India and China. According to the International Diabetes Federation, nearly 7.2
billion individuals are suffering from diabetes in India and around 11.4
billion people are suffering from diabetes in China.
The report on global needle free drug delivery devices market
covers segments such as technology, and application. On the basis of
technology, the sub-markets include jet injectors, inhaler technology,
transdermal patch technology, novel needle-free technologies, and oral drug
delivery system. On the basis of application, the sub-markets include vaccine
delivery, pain management, insulin delivery for diabetes, pediatric injections,
and other applications.
The report provides profiles of the companies in the market such
as 3M, AkraDermojet Inc, Antares Pharma Inc., Bayer AG, Bioject Medical
Technologies, Inc., GlaxoSmithKline plc, Glide Pharmaceutical Technologies Ltd.,
InjexPharma AG, Medtronic, Inc., Zogenix, Inc., and other companies.
The report provides deep insights into the demand forecasts,
market trends, and micro and macro indicators. In addition, this report
provides insights into the factors that are driving and restraining the growth
in this market. Moreover, The IGR-Growth Matrix analysis given in the report
brings an insight into the investment areas that existing or new market players
can consider. The report provides insights into the market using analytical
tools such as Porter's five forces analysis and DRO analysis of needle free
drug delivery devices market. Moreover, the study highlights current market
trends and provides forecast from 2019-2025. We also have highlighted future
trends in the market that will affect the demand during the forecast period.
Moreover, the competitive analysis given in each regional market brings an
insight into the market share of the leading players.